Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.9591
-0.0145 (-1.49%)
At close: Apr 1, 2025, 4:00 PM
0.9496
-0.0095 (-0.99%)
After-hours: Apr 1, 2025, 5:01 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $13.43 million as of April 1, 2025. Its market cap has decreased by -16.08% in one year.
Market Cap
13.43M
Enterprise Value
9.63M
1-Year Change
-16.08%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $13.43M, a decrease of -81.01%. That is a compound annual growth rate of -17.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 13.60M | 166.67% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.23B |
| UnitedHealth Group | 480.16B |
| Johnson & Johnson | 399.99B |
| AbbVie | 368.05B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 229.16B |
| Merck & Co. | 225.42B |